首页> 外文期刊>Physiological Research >Plasma Obestatin Levels in Normal Weight, Obese and Anorectic Women
【24h】

Plasma Obestatin Levels in Normal Weight, Obese and Anorectic Women

机译:正常体重,肥胖和厌食症妇女的血浆雌激素水平

获取原文
获取原文并翻译 | 示例
           

摘要

Obestatin is a recently discovered peptide produced in thestomach, which was originally described to suppress food intake and decrease body weight in experimental animals. We investigated fasting plasma obestatin levels in normal weight, obese and anorectic women and associations of plasma obestatin levels with anthropometric and hormonal parameters. Hormonal (obestatin, ghrelin, leptin, insulin) and anthropometric parameters and body composition were examined in 15 normal weight, 21 obese and 15 anorectic women. Fasting obestatinlevels were significantly lower in obese than in normal weight and anorectic women, whereas ghrelin to obestatin ratio was increased in anorectic women. Compared to leptin, only minor differences in plasma obestatin levels were observed in women who greatly differed in the amount of fat stores. However, a negative correlation of fasting obestatin level with body fat indexes might suggest a certain role of obestatin in the regulation of energy homeostasis. A significant relationship een plasma obestatin and ghrelin levels, independent of anthropometric parameters, supports simultaneous secretion of both hormones from the common precursor. Lower plasma obestatin levels in obese women compared to normal weight and anorectic women as well as increased ghrelin to obestatin ratio in anorectic women might play a role in body weight regulation in these pathologies.
机译:肥胖抑制素是最近发现的在胃中产生的肽,最初被描述为抑制实验动物的食物摄入并减轻其体重。我们调查了正常体重,肥胖和厌食症妇女的空腹血浆肥胖抑制素水平,以及血浆肥胖抑制素水平与人体测量学和激素参数的相关性。在15名正常体重,21名肥胖和15名厌食妇女中检查了激素(obestatin,ghrelin,leptin,胰岛素)以及人体测量学参数和身体组成。肥胖者的空腹肥胖素水平显着低于正常体重和厌食妇女,而厌食素中生长素释放肽与肥胖素的比率增加。与瘦蛋白相比,在脂肪储存量上有很大差异的女性中,血浆肥胖素水平仅有微小差异。然而,空腹抑素水平与人体脂肪指数呈负相关,这可能暗示了抑素在能量稳态中的一定作用。血浆肥胖抑制素和生长激素释放肽水平的显着关系与人体测量学参数无关,支持从共同的前体中同时分泌两种激素。与正常体重和厌食妇女相比,肥胖妇女的血浆血浆雌激素水平较低,以及厌食妇女中生长素释放肽与肥胖素的比率增加,可能在这些疾病的体重调节中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号